To determine the mechanisms underlying TAK1‐mediated suppression of cell proliferation in esophageal tumor, we performed co‐immunoprecipitation coupled with mass spectrometry analysis to identify the downstream targets of TAK1. Here, MAP3K7 is linked to neoplasm of esophagus.